InvestorsObserver
×
News Home

Tonix Pharmaceuticals Holding Corp (TNXP) Down 1.96% in Premarket Trading

Wednesday, August 31, 2022 09:01 AM | InvestorsObserver Analysts

Mentioned in this article

Tonix Pharmaceuticals Holding Corp (TNXP) Down 1.96% in Premarket Trading

Tonix Pharmaceuticals Holding Corp (TNXP) is down Wednesday morning, with the stock losing -1.96% in pre-market trading to 1. TNXP's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 126 out of 146 industries, Tonix Pharmaceuticals Holding Corp ranks higher than 21% of stocks. Tonix Pharmaceuticals Holding Corp has fallen 39.29% over the past month, closing at $1.77 on August 3. During this period of time, the stock fell as low as $1.02 and as high as $1.94. TNXP has an average analyst recommendation of Strong Buy. The company has an average price target of $13.00.

Overall Score - 47
TNXP has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TNXP!
Tonix Pharmaceuticals Holding Corp has a Long-Term Technical rank of 58. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 42% of the market scoring higher. In the Biotechnology industry which is number 78 by this metric, TNXP ranks better than 78% of stocks.

Important Dates for Investors in TNXP:

-Tonix Pharmaceuticals Holding Corp is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-6.66. -We do not have a set dividend date for Tonix Pharmaceuticals Holding Corp at this time. Click Here To Get The Full Report on Tonix Pharmaceuticals Holding Corp (TNXP)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App